Asterias Biotherapeutics (AST) Announces Start of AST-OPC1 Phase 1/2a Enrollment
Tweet Send to a Friend
Asterias Biotherapeutics (AMEX: AST) announced that Atlanta-based Shepherd Center, one of the nation's top rehabilitation hospitals for spinal cord injury ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE